Product Information

LEVALBUTEROL CONC 1.25 MG/0.5 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $5.2385 per EA under NDC 00378699393. Its NADAC has been published 349 times since Nov 28, 2013.

FDA first approved this application on Mar 20, 2009. Its Orange Book therapeutic-equivalence code is AN.

LEVALBUTEROL CONC 1.25 MG/0.5

levalbuterol
$5.2385per EA

Strength

1.25 mg/.5mL

NDC

00378699393

Classification

Generic

Dosage Form

SOLUTION, CONCENTRATE

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Active Ingredients

LEVALBUTEROL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078309

FDA Approved

3/20/2009

TE Code

AN

On Market Since

8/28/2009

Pharmacological Classes

Adrenergic beta2-Agonists
beta2-Adrenergic Agonist

Price Statistics

The NADAC for LEVALBUTEROL CONC 1.25 MG/0.5 has been published 349 times since Nov 28, 2013, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.2385 per EA
All-time high$5.8349 (May 14, 2014)
All-time low$3.6998 (Oct 23, 2024)
52-week high$5.2385
52-week low$4.1407
Median price$4.7786
Average price$4.7383
Largest weekly change+26.5% (Aug 19, 2026)
Weeks tracked349
Tracking sinceNov 28, 2013

Price History

1W

+26.5%

1M

+26.5%

3M

+26.5%

6M

+26.5%

1Y

+26.5%

3Y

+36.5%

5Y

+36.5%

All

-3.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levalbuterol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LEVALBUTEROL CONC 1.25 MG/0.5?

The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL CONC 1.25 MG/0.5, manufactured by Mylan Pharmaceuticals Inc., is $5.2385 per EA (NDC 00378699393), effective Aug 19, 2026.

How has the price of LEVALBUTEROL CONC 1.25 MG/0.5 changed over time?

Over the history we have for it, the NADAC for LEVALBUTEROL CONC 1.25 MG/0.5 has declined 3.3%. It has been tracked across 349 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVALBUTEROL CONC 1.25 MG/0.5?

Since Nov 28, 2013, the NADAC for LEVALBUTEROL CONC 1.25 MG/0.5 has ranged from a low of $3.6998 (Oct 23, 2024) to a high of $5.8349 (May 14, 2014), with a median of $4.7786 per EA.

Are there cheaper alternatives to LEVALBUTEROL CONC 1.25 MG/0.5?

No other NADAC-published product currently shares the active ingredient and strength of LEVALBUTEROL CONC 1.25 MG/0.5 in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LEVALBUTEROL CONC 1.25 MG/0.5?

LEVALBUTEROL CONC 1.25 MG/0.5 (NDC 00378699393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.